Table 6.

Most Important Factor (Benefit or Harm) in Decision Making: Aspirin

	All	F	M	HGD	No HGD
All participants
Number of subjects	100	28	72	45	55
EAC	66%	68%	65%	64%	67%
MI	11%	18%	8%	7%	15%
GI event	23%	14%	26%	29%	18%
Among those willing to take aspirin
Number of subjects	76	23	53	31	45
EAC	86%	78%	89%	90%	94%
MI	14%	22%	11%	10%	16%
GI event	0	0	0	0	0
Among those unwilling take aspirin
Number of subjects	24	5	19	14	10
EAC	4%	20%	0	7%	0
MI	0	0	0	0	0
GI event	96%	80%	100%	93%	100%

All = total group surveyed; HGD = history of high-grade dysplasia.

Percentages do not always add to 100% because of rounding.

EAC = esophageal adenocarcinoma; MI = myocardial infarction; GI event = ulcer or gastrointestinal bleeding.